Weighing the impact of a "wait and see" approach to inflation
Shifting payment models call for hospital investment in new technology areas
Balancing innovation and the public good in autonomous vehicles
Timely insights to inform your agenda
Many drug makers are increasingly swimming in new sources of data. Find out how they can channel real-world evidence to influence patient behavior, answer hard questions on what works for whom and at what price, and power the future of health care.
Deloitte Review View all
Finding great talent has arguably never been tougher. But major companies may be overlooking their greatest source of versatile, ambitious professionals—themselves.
Explore the latest issue of Deloitte Review now.